Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Walmart Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $844.0B | |
|---|---|---|
| Revenue (ttm) | 735.8B | |
| Net income (ttm) | 22.1B | |
| EPS (ttm) | $2.76 | |
| Shares out | 7.9B | |
| P/E (trailing) | 43.0x | |
| P/E (forward) | 36.8x | |
| Dividend | $0.99 (0.83%) | |
| Volume | 10,107,180 | |
| Beta | 0.58 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2026-01-31 | Trend |
| Revenue | $567.76B | $605.88B | $642.64B | $674.54B | $706.41B | +5.6% |
| Gross profit | $143.75B | $147.57B | $157.98B | $169.23B | $177.77B | +5.5% |
| Operating income | $25.94B | $20.43B | $27.01B | $29.35B | $29.83B | +3.5% |
| Net income | $13.67B | $11.68B | $15.51B | $19.44B | $21.89B | +12.5% |
| EPS (diluted) | $1.62 | $1.42 | $1.91 | $2.41 | $2.73 | +13.9% |
| EBITDA | $31.35B | $30.09B | $36.38B | $42.01B | $46.47B | +10.3% |
| R&D | — | — | — | — | — | — |
| SG&A | $117.81B | $127.14B | $130.97B | $139.88B | $147.94B | +5.9% |
Recent company headlines from major financial publishers.
This path would allow more operating cash to become free cash flow. It fades if investment intensity remains high through FY2029 or segment margins weaken.
This path depends on meeting the FY2028 revenue and earnings estimates while preserving Walmart U.S. operating profitability. It weakens if annual Walmart U.S. revenue growth stays below 3% or operating margin stays below 4.8% for two consecutive fiscal years. Either breach would reduce consolidated sales, profit, earnings per share and free cash flow.
| Ke ↓ / g → | 2.6% | 3.1% | 3.6% | 4.1% | 4.6% |
|---|---|---|---|---|---|
| 5.7% | $97.5 | $110 | $130 | $167 | $261 |
| 6.7% | $78.7 | $84.9 | $93.2 | $105 | $124 |
| 7.7% | $67.7 | $71.2 | $75.7 | $81.5 | $89.3 |
| 8.7% | $60.3 | $62.6 | $65.3 | $68.6 | $72.8 |
| 9.7% | $55.1 | $56.6 | $58.4 | $60.5 | $63.0 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
